ATE525371T1 - Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon - Google Patents
Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davonInfo
- Publication number
- ATE525371T1 ATE525371T1 AT06828254T AT06828254T ATE525371T1 AT E525371 T1 ATE525371 T1 AT E525371T1 AT 06828254 T AT06828254 T AT 06828254T AT 06828254 T AT06828254 T AT 06828254T AT E525371 T1 ATE525371 T1 AT E525371T1
- Authority
- AT
- Austria
- Prior art keywords
- imidazole
- salts
- acid derivatives
- production
- carbonic acid
- Prior art date
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- NKWCGTOZTHZDHB-UHFFFAOYSA-N 1h-imidazol-1-ium-4-carboxylate Chemical class OC(=O)C1=CNC=N1 NKWCGTOZTHZDHB-UHFFFAOYSA-N 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2006/003301 WO2008067687A1 (fr) | 2006-12-06 | 2006-12-06 | Sels de dérivés d'acide imidazol-5-carboxylique, procédés de préparation et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE525371T1 true ATE525371T1 (de) | 2011-10-15 |
Family
ID=39491635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06828254T ATE525371T1 (de) | 2006-12-06 | 2006-12-06 | Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7943648B2 (de) |
| EP (1) | EP2103610B1 (de) |
| JP (1) | JP5290190B2 (de) |
| KR (1) | KR101112515B1 (de) |
| AT (1) | ATE525371T1 (de) |
| AU (1) | AU2006351517B8 (de) |
| CA (1) | CA2671816C (de) |
| WO (1) | WO2008067687A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101024643A (zh) | 2006-02-20 | 2007-08-29 | 上海艾力斯医药科技有限公司 | 咪唑－5－羧酸类衍生物、制备方法及其应用 |
| CN101214242A (zh) * | 2007-01-05 | 2008-07-09 | 上海艾力斯医药科技有限公司 | 新的药用组合物 |
| CN101317842A (zh) * | 2007-06-07 | 2008-12-10 | 上海艾力斯医药科技有限公司 | 一种咪唑-5-羧酸衍生物的治疗用途 |
| CN101407511B (zh) | 2007-10-11 | 2013-01-09 | 上海艾力斯生物医药有限公司 | 一种结晶型的咪唑-5-羧酸衍生物 |
| CN101596189A (zh) * | 2008-06-05 | 2009-12-09 | 上海艾力斯生物医药有限公司 | 含有咪唑-5-羧酸类衍生物的药用组合物 |
| AU2010313521B2 (en) * | 2009-10-26 | 2014-01-30 | Lexicon Pharmaceuticals, Inc. | Methods of preparing 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone |
| WO2012039447A1 (ja) * | 2010-09-24 | 2012-03-29 | 第一三共株式会社 | 置換シクロアルケン誘導体の結晶 |
| CN106188012B (zh) * | 2014-06-20 | 2018-11-30 | 深圳信立泰药业股份有限公司 | 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1334092C (en) | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| US5616599A (en) | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| AT398202B (de) * | 1991-10-04 | 1994-10-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
| US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| KR20060056352A (ko) * | 2003-07-31 | 2006-05-24 | 니콕스 에스. 에이. | 안지오텐신ⅱ 수용체 차단제 유도체들 |
| AU2004270162B2 (en) * | 2003-08-28 | 2010-05-13 | Nicox S.A. | Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| DE602006010364D1 (de) * | 2005-04-22 | 2009-12-24 | Daiichi Sankyo Co Ltd | Pharmazeutikum zur prävention oder behandlung von metabolischer knochenkrankheit |
| CN101024643A (zh) * | 2006-02-20 | 2007-08-29 | 上海艾力斯医药科技有限公司 | 咪唑－5－羧酸类衍生物、制备方法及其应用 |
| CN101195615B (zh) * | 2006-12-06 | 2013-03-27 | 深圳市信立泰资产管理有限公司 | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 |
-
2006
- 2006-12-06 WO PCT/CN2006/003301 patent/WO2008067687A1/zh active Application Filing
- 2006-12-06 AT AT06828254T patent/ATE525371T1/de not_active IP Right Cessation
- 2006-12-06 CA CA2671816A patent/CA2671816C/en not_active Expired - Fee Related
- 2006-12-06 JP JP2009539584A patent/JP5290190B2/ja not_active Expired - Fee Related
- 2006-12-06 KR KR1020097013694A patent/KR101112515B1/ko not_active IP Right Cessation
- 2006-12-06 EP EP06828254A patent/EP2103610B1/de not_active Not-in-force
- 2006-12-06 AU AU2006351517A patent/AU2006351517B8/en not_active Ceased
-
2009
- 2009-06-05 US US12/478,954 patent/US7943648B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2103610B1 (de) | 2011-09-21 |
| CA2671816A1 (en) | 2008-06-12 |
| AU2006351517A1 (en) | 2008-06-12 |
| KR101112515B1 (ko) | 2012-02-24 |
| JP5290190B2 (ja) | 2013-09-18 |
| JP2010511636A (ja) | 2010-04-15 |
| WO2008067687A1 (fr) | 2008-06-12 |
| EP2103610A4 (de) | 2011-01-05 |
| AU2006351517B2 (en) | 2011-12-22 |
| US7943648B2 (en) | 2011-05-17 |
| CA2671816C (en) | 2012-06-05 |
| AU2006351517B8 (en) | 2012-01-19 |
| EP2103610A1 (de) | 2009-09-23 |
| KR20100004917A (ko) | 2010-01-13 |
| US20090326024A1 (en) | 2009-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE525371T1 (de) | Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon | |
| EA200970611A1 (ru) | Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы | |
| WO2008094992A3 (en) | 2-aminopyridine derivatives useful as kinase inhibitors | |
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| ATE518824T1 (de) | Substituierte cyclohexylmethyl-derivate | |
| EA201170249A1 (ru) | 3,4-диарилпиразолы в качестве ингибиторов протеинкиназ | |
| EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты | |
| MY148483A (en) | 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments | |
| WO2008147557A3 (en) | Heteroaryl substituted thiazoles and their use as antiviral agents | |
| EA201200763A1 (ru) | Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep | |
| EA201101671A1 (ru) | Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина | |
| EA201200318A1 (ru) | Гетероциклические оксимы | |
| EA200800147A1 (ru) | Способ получения олмесартан медоксомила | |
| ATE473221T1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus | |
| WO2007150026A3 (en) | Purinone derivatives as hm74a agonists | |
| MX2020005735A (es) | Derivados de glutarimida, uso de los mismos, composición farmacéutica basada en los mismos y métodos para producir derivados de glutarimida. | |
| EA201071120A1 (ru) | Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида | |
| ATE435223T1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| ATE492534T1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| WO2010121675A3 (en) | Thiazolyl-benzimidazoles | |
| EA201070543A1 (ru) | Новые 4-(тетразол-5-ил) хиназолиновые производные в качестве противораковых средств | |
| DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
| NO20075209L (no) | Substituerte aryl 1,4-pyrazinderivater | |
| NZ591837A (en) | Amino acid derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |